These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

148 related items for PubMed ID: 9732912

  • 1. Rationale and design of the Myocardial Ischemia Reduction With Aggressive Cholesterol lowering (MIRACL) Study that evaluates atorvastatin in unstable angina pectoris and in non-Q-wave acute myocardial infarction.
    Ghali JK.
    Am J Cardiol; 1998 Sep 01; 82(5):703. PubMed ID: 9732912
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. [Meeting report. "MIRACL" study of "Myocardial Ischemia Reduction with Aggressive Cholesterol Lowering"].
    Scheen AJ.
    Rev Med Liege; 2000 Dec 01; 55(12):1064-6. PubMed ID: 11205194
    [Abstract] [Full Text] [Related]

  • 5. Effect of atorvastatin on risk of recurrent cardiovascular events after an acute coronary syndrome associated with high soluble CD40 ligand in the Myocardial Ischemia Reduction with Aggressive Cholesterol Lowering (MIRACL) Study.
    Kinlay S, Schwartz GG, Olsson AG, Rifai N, Sasiela WJ, Szarek M, Ganz P, Libby P, Myocardial Ischemia Reduction with Aggressive Cholesterol Lowering (MIRACL) Study Investigators.
    Circulation; 2004 Jul 27; 110(4):386-91. PubMed ID: 15262833
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. What is the role of intensive cholesterol lowering in the treatment of acute coronary syndromes?
    Waters DD, Hsue PY.
    Am J Cardiol; 2001 Oct 11; 88(7B):7J-16J. PubMed ID: 11595193
    [Abstract] [Full Text] [Related]

  • 9. [Statins and unstable angina: MIRACL].
    Puel J.
    Ann Endocrinol (Paris); 2001 Feb 11; 62(1 Pt 2):145-8. PubMed ID: 11240417
    [Abstract] [Full Text] [Related]

  • 10. Effects of atorvastatin on early recurrent ischemic events in acute coronary syndromes: the MIRACL study: a randomized controlled trial.
    Schwartz GG, Olsson AG, Ezekowitz MD, Ganz P, Oliver MF, Waters D, Zeiher A, Chaitman BR, Leslie S, Stern T, Myocardial Ischemia Reduction with Aggressive Cholesterol Lowering (MIRACL) Study Investigators.
    JAMA; 2001 Apr 04; 285(13):1711-8. PubMed ID: 11277825
    [Abstract] [Full Text] [Related]

  • 11. A pharmacoeconomic evaluation of the Myocardial Ischaemia Reduction with Aggressive Cholesterol Lowering (MIRACL) study in the United Kingdom.
    Buller N, Gillen D, Casciano R, Doyle J, Wilson K.
    Pharmacoeconomics; 2003 Apr 04; 21 Suppl 1():25-32. PubMed ID: 12648032
    [Abstract] [Full Text] [Related]

  • 12. Lipid-lowering therapy in acute coronary syndromes.
    Sacks FM.
    JAMA; 2001 Apr 04; 285(13):1758-60. PubMed ID: 11277832
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. [Cost-effectiveness of atorvastatin in the early treatment of acute coronary syndromes in Germany based on the MIRACL study].
    Lange AP, Szucs TD.
    Med Klin (Munich); 2004 Sep 15; 99(9):500-5. PubMed ID: 15372179
    [Abstract] [Full Text] [Related]

  • 15. Effects of atorvastatin 80 mg daily early after onset of unstable angina pectoris or non-Q-wave myocardial infarction.
    Colivicchi F, Guido V, Tubaro M, Ammirati F, Montefoschi N, Varveri A, Santini M.
    Am J Cardiol; 2002 Oct 15; 90(8):872-4. PubMed ID: 12372577
    [No Abstract] [Full Text] [Related]

  • 16. Can early treatment with atorvastatin (Lipitor) improve the outcome of patients with acute coronary syndromes?
    Johnson K, Breen WJ.
    J Fam Pract; 2001 Jul 15; 50(7):572. PubMed ID: 11485701
    [No Abstract] [Full Text] [Related]

  • 17. High-dose atorvastatin enhances the decline in inflammatory markers in patients with acute coronary syndromes in the MIRACL study.
    Kinlay S, Schwartz GG, Olsson AG, Rifai N, Leslie SJ, Sasiela WJ, Szarek M, Libby P, Ganz P, Myocardial Ischemia Reduction with Aggressive Cholesterol Lowering Study Investigators.
    Circulation; 2003 Sep 30; 108(13):1560-6. PubMed ID: 12975259
    [Abstract] [Full Text] [Related]

  • 18. A pharmacoeconomic evaluation of the effects of atorvastatin on early recurrent ischemic events in acute coronary syndromes in Spain.
    Gómez-Gerique JA, Casciano R, Stern L, Rejas J.
    Eur J Health Econ; 2004 Oct 30; 5(3):278-84. PubMed ID: 15714350
    [Abstract] [Full Text] [Related]

  • 19. Short-term effect of atorvastatin (80 mg) on plasma lipids of patients with unstable angina pectoris or non-Q-wave acute myocardial infarction.
    Correia LC, Spósito AC, Passos LC, Lima JC, Braga JC, Rocha MS, Esteves JP, D'Oliveira A.
    Am J Cardiol; 2002 Jul 15; 90(2):162-4. PubMed ID: 12106850
    [No Abstract] [Full Text] [Related]

  • 20. Aggressive lowering of low-density lipoprotein cholesterol: do the studies apply to the elderly?
    DeSilvey DL.
    Am J Geriatr Cardiol; 2004 Jul 15; 13(4):217-8. PubMed ID: 15269569
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.